Differential anti-cancer signaling exerted by an in silico-designed compound in tumorigenic and non-tumorigenic breast cells

Microtubule-disrupting agents have been studied for decades for their potential anticancer activity and resulted in discovery of an endogenous 17β-estradiol derivative, 2-methoxyestradiol (2ME2). Since 2ME2 possesses low bioavailability, several analogues with improved efficacy was in silico-designe...

Full description

Bibliographic Details
Main Author: Visagie, M.H. (Michelle Helen)
Other Authors: Joubert, Annie M.
Language:en
Published: University of Pretoria 2014
Subjects:
Online Access:http://hdl.handle.net/2263/40255
Visagie, M(H 2014, Differential anti-cancer signaling exerted by an in silico-designed compound in tumorigenic and non-tumorigenic breast cells, PhD Thesis, University of Pretoria, Pretoria, viewed yymmdd <http://hdl.handle.net/2263/40255>